- Upregulation of Tim‐3 is associated with poor prognosis in acute myeloid leukemia
Zhengwei Wu et al, 2023, Cancer Medicine CrossRef - Siglec-6 CAR T: magic bullet for a moving target
Sara Ghorashian et al, 2021, Blood CrossRef - Immune checkpoints and cancer immunotherapies: insights into newly potential receptors and ligands
Ali N. Kamali et al, 2023, Therapeutic Advances in Vaccines and Immunotherapy CrossRef - The role of bone marrow microenvironment (BMM) cells in acute myeloid leukemia (AML) progression: immune checkpoints, metabolic checkpoints, and signaling pathways
Maryam Bakhtiyari et al, 2023, Cell Communication and Signaling CrossRef - Genetic signature of CTLA-4, BTLA, TIM-3 and LAG-3 molecular expression in colorectal cancer patients: Implications in diagnosis and survival outcomes
Amany M. Kamal et al, 2021, Clinical Biochemistry CrossRef - TIM-3 Expression Level on AML Blasts Correlates With Presence of Core Binding Factor Translocations Rather Than Clinical Outcomes
Jian Hong et al, 2022, Frontiers in Oncology CrossRef - Immunotherapy in leukaemia
Xingmei Mu et al, 2023, Acta Biochimica et Biophysica Sinica CrossRef - A T-cell receptor as a promising immunotherapeutic target in acute myeloid leukemia: expression of T cell immunoglobulin and mucin-containing-3 on bone marrow hematopoietic cells
Heba M Atif et al, 2024, The Egyptian Journal of Haematology CrossRef - The prospective prognostic value of the immune checkpoint BTLA expression in adult acute myeloid leukemia patients
Sara M. Radwan et al, 2021, Egyptian Journal of Medical Human Genetics CrossRef - NPM1 and DNMT3A mutations are associated with distinct blast immunophenotype in acute myeloid leukemia
Kateřina Kuželová et al, 2022, OncoImmunology CrossRef - The role of circular RNA plasmacytoma variant translocation 1 as a biomarker for prognostication of acute myeloid leukemia
Tao Chen et al, 2021, Hematology CrossRef - Activated Tim-3/Galectin-9 participated in the development of multiple myeloma by negatively regulating CD4 T cells
Rui Zhang et al, 2024, Hematology CrossRef - Catch me if you can: how AML and its niche escape immunotherapy
Sarah Tettamanti et al, 2022, Leukemia CrossRef